TickerTain
Newsroom
Portfolio
Feed
Convergence
Leaderboard
Shorts
Sign in
Newsroom
Portfolio
Feed
Convergence
Leaderboard
Shorts
Sign in
$SPCX
···
·
$NVDA
···
·
$MSFT
···
·
$GOOGL
···
·
$ANTHROPIC
·
$TSLA
···
·
$CRWV
···
·
$NBIS
···
·
$HIMS
···
·
$TSM
···
·
$ASML
···
·
$FIGURE
·
$LYFT
···
·
$UBER
···
·
$SNOW
···
·
$META
···
·
$ELEVENLABS
·
$CURSOR
·
$COGNITION
·
$OPENAI
·
$AAPL
···
·
$RKLB
···
·
$XAI
·
$AMZN
···
·
$AMD
···
·
$000660.KS
···
·
$INTC
···
·
$SPCX
···
·
$NVDA
···
·
$MSFT
···
·
$GOOGL
···
·
$ANTHROPIC
·
$TSLA
···
·
$CRWV
···
·
$NBIS
···
·
$HIMS
···
·
$TSM
···
·
$ASML
···
·
$FIGURE
·
$LYFT
···
·
$UBER
···
·
$SNOW
···
·
$META
···
·
$ELEVENLABS
·
$CURSOR
·
$COGNITION
·
$OPENAI
·
$AAPL
···
·
$RKLB
···
·
$XAI
·
$AMZN
···
·
$AMD
···
·
$000660.KS
···
·
$INTC
···
·
← newsroom
$KERNEL
· Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World... Here's What It Was Like
company · 2
thematic · 6
now playing ·
$KERNEL
▶ play all
7:14
▶ play
$KERNEL
bullish
· high
· pos
bryan johnson
Kernel brain interface quantifies psychedelic-induced neuroplasticity
Bryan Johnson's Kernel optical brain interface captures high-fidelity neural data showing psilocybin and 5-MeO-DMT dramatically rewire default mode network connectivity, enabling…
32:14
▶ play
$NEWLIMIT
bullish
· high
· pos
bryan johnson
Bryan Johnson invests in NewLimit for epigenetic reprogramming
Johnson is a personal investor in NewLimit, which has computationally accelerated Yamanaka factor discovery for epigenetic reprogramming, achieving remarkable progress in partial…